Pharmaceuticals
-
New generation BRAF inhibitor shows promise
A drug designed to work against a range of BRAF mutations in several cancers is showing early promise, a European conference heard last night. Read more
-
COVID-19 vaccine trials do not assess severe disease
Mass vaccination could be introduced against COVID-19 without any evidence indicating it could save lives, an expert warns today. Read more
-
Asthma treatments linked to bone health
Some asthma treatments may be linked to a raised risk of osteoporosis and fracture, researchers warn today. Read more
-
Measures to prevent dementia ‘cost-effective’
Interventions for preventing dementia in England could be cost-effective, saving over a billion pounds per year, and could significantly reduce dementia rates, according to a new analysis. Read more
-
Drugs disappointment triggers call for COVID-19 investment
The world will need to pump billions more into COVID-19 studies after a series of disappointing drug trials, experts have said. Read more
-
Appeal for new vaccine volunteers
An appeal was launched today for minority groups to sign up to take part in the UK’s trials of COVID-19 vaccines. Read more
-
No evidence of antiviral benefit against COVID-19 – major trial
A powerful antiviral drug combination has proved ineffective in treating COVID-19 infection, according to the latest findings from a major study. Read more
-
Game changer’ paediatric neuroblastoma drug trial announced
A recently developed drug could be a “game changer” treatment for children with neuroblastoma, it was announced today. Read more
-
Treatment hope for HER2+ breast cancer patients
Women with early HER2+ breast cancer survive longer if they are prescribed lapatinib and trastuzumab before surgery, the results of a Spanish trial have revealed. Read more
-
Care homes to test anti-inflammatory virus treatment
An anti-tumour necrosis factor drug is to be tested as a community treatment for COVID-19 infection, it has been announced. Read more
